We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBN icon
9476
Northeast Bank
NBN
$1.14B
$218K ﹤0.01%
+9,678
New +$204K
RCEL icon
9477
CALL
Avita Medical
RCEL
$142M
$218K ﹤0.01%
11,740
+3,640
+45% +$79.8K
RCKY icon
9478
Rocky Brands
RCKY
$374M
$218K ﹤0.01%
7,775
-825
-10% -$23.5K
ROKT icon
9479
State Street SPDR S&P Kensho Final Frontiers ETF
ROKT
$242M
$218K ﹤0.01%
+5,606
New +$198K
VRS
9480
CALL
DELISTED
Verso Corporation
VRS
$218K ﹤0.01%
+18,100
New +$179K
GCC icon
9481
WisdomTree Enhanced Commodity Strategy Fund
GCC
$271M
$217K ﹤0.01%
+11,417
New +$206K
IBIO icon
9482
CALL
iBio
IBIO
$69.5M
$217K ﹤0.01%
413
-49
-11% -$39.9K
MX icon
9483
Magnachip Semiconductor
MX
$134M
$217K ﹤0.01%
16,025
-12,415
-44% -$171K
OOMA icon
9484
PUT
Ooma
OOMA
$590M
$217K ﹤0.01%
15,100
+4,900
+48% +$72.4K
VEDL
9485
PUT
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$217K ﹤0.01%
24,700
-29,000
-54% -$189K
CRK icon
9486
CALL
Comstock Resources
CRK
$3.81B
$216K ﹤0.01%
49,500
+30,600
+162% +$152K
DEI icon
9487
CALL
Douglas Emmett
DEI
$1.98B
$216K ﹤0.01%
+7,400
New +$210K
WAFD icon
9488
CALL
WaFd
WAFD
$2.79B
$216K ﹤0.01%
+8,400
New +$200K
GENE
9489
CALL
DELISTED
Genetic Technologies Ltd.
GENE
$216K ﹤0.01%
12,020
+3,720
+45% +$61.5K
GTT
9490
CALL
DELISTED
GTT Communications, Inc.
GTT
$216K ﹤0.01%
60,600
+6,700
+12% +$28.9K
CEMI
9491
CALL
DELISTED
Chembio diagnostics, Inc.
CEMI
$216K ﹤0.01%
45,500
-19,400
-30% -$100K
DAO
9492
CALL
Youdao
DAO
$2.08B
$215K ﹤0.01%
+8,100
New +$225K
GOSS icon
9493
CALL
Gossamer Bio
GOSS
$86.9M
$215K ﹤0.01%
+22,200
New +$219K
PALL icon
9494
abrdn Physical Palladium Shares ETF
PALL
$661M
$215K ﹤0.01%
+4,690
New +$206K
RICK icon
9495
RCI Hospitality Holdings
RICK
$198M
$215K ﹤0.01%
+5,453
New +$150K
SKF icon
9496
ProShares UltraShort Financials
SKF
$9.9M
$215K ﹤0.01%
+1,704
New +$262K
LBC
9497
DELISTED
Luther Burbank Corporation Common Stock
LBC
$215K ﹤0.01%
+21,922
New +$216K
PRTK
9498
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$215K ﹤0.01%
34,400
+8,700
+34% +$51.2K
DPST icon
9499
Direxion Daily Regional Banks Bull 3X ETF
DPST
$462M
$214K ﹤0.01%
889
-12,584
-93% -$2.2M
DSL
9500
PUT
DoubleLine Income Solutions Fund
DSL
$1.22B
$214K ﹤0.01%
12,900
-5,500
-30% -$89.3K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.